BIONET Corp. (TPEX: 1784)

Market Cap	4.86B
Revenue (ttm)	1.18B
Net Income (ttm)	55.72M
Shares Out	50.65M
EPS (ttm)	1.10
PE Ratio	86.86
Forward PE	n/a
Dividend	0.66 (0.75%)
Ex-Dividend Date	Sep 19, 2024

Volume	1,560,239
Open	96.50
Previous Close	95.90
Day's Range	93.80 - 99.50
52-Week Range	50.05 - 162.01
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About BIONET

BIONET Corp. provides cord blood banking services in Taiwan and internationally. The company offers stem cell banking services, including stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC + immune cells; and genetic testing services. It also provides stem anti-aging and ANIKINE series products. In addition, the company offers Exosome, a novel cell-free therapy. The company was founded in 1989 and is based in Taipei City, Taiwan.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1989
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1784

Financial Performance

In 2023, BIONET's revenue was 1.13 billion, an increase of 14.99% compared to the previous year's 980.38 million. Earnings were 78.40 million, an increase of 106.47%.